Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Ledermann

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 23, 2008
Primary tumour resection and survival in the palliative management of metastatic colorectal cancerA Bajwa, N Blunt, S Vyas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 1998
Iodine-131-MIBG therapy of a patient with carcinoid liver metastasesE M Prvulovich, R C Stein, J B Bomanji, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 1, 1991
Weekly etoposide, methotrexate and actinomycin D, alternating with cyclophosphamide plus vincristine (EMA/CO): a phase II study in advanced gastric carcinomaP A Philip, G J Rustin, J A Ledermann, et al.
British Journal of Cancer|September 1, 2011
Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancerF A Raja, C L Griffin, W Qian, et al.
British Journal of Cancer|February 12, 1998
Biodistribution of a radiolabelled monoclonal antibody NY3D11 recognizing the neural cell adhesion molecule in tumour xenografts and patients with small-cell lung cancerD Ornadel, J A Ledermann, K Eagle, et al.
British Journal of Urology|August 1, 1994
The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumoursJ A Ledermann, L Holden, E S Newlands, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1986
Is ectopic production of human chorionic gonadotrophin (hCG) or alpha fetoprotein (AFP) by tumours a marker of chemosensitivity?S M Crawford, J A Ledermann, W Turkie, et al.
British Journal of Cancer|January 1, 1997
A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastasesJ D Howell, C S McArdle, D J Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracilD J Kerr, J A Ledermann, C S McArdle, et al.
British Journal of Cancer|February 1, 1994
The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodiesY Olabiran, J A Ledermann, N J Marston, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 23, 2008
Primary tumour resection and survival in the palliative management of metastatic colorectal cancerA Bajwa, N Blunt, S Vyas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 1998
Iodine-131-MIBG therapy of a patient with carcinoid liver metastasesE M Prvulovich, R C Stein, J B Bomanji, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 1, 1991
Weekly etoposide, methotrexate and actinomycin D, alternating with cyclophosphamide plus vincristine (EMA/CO): a phase II study in advanced gastric carcinomaP A Philip, G J Rustin, J A Ledermann, et al.
British Journal of Cancer|September 1, 2011
Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancerF A Raja, C L Griffin, W Qian, et al.
British Journal of Cancer|February 12, 1998
Biodistribution of a radiolabelled monoclonal antibody NY3D11 recognizing the neural cell adhesion molecule in tumour xenografts and patients with small-cell lung cancerD Ornadel, J A Ledermann, K Eagle, et al.
British Journal of Urology|August 1, 1994
The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumoursJ A Ledermann, L Holden, E S Newlands, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1986
Is ectopic production of human chorionic gonadotrophin (hCG) or alpha fetoprotein (AFP) by tumours a marker of chemosensitivity?S M Crawford, J A Ledermann, W Turkie, et al.
British Journal of Cancer|January 1, 1997
A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastasesJ D Howell, C S McArdle, D J Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracilD J Kerr, J A Ledermann, C S McArdle, et al.
British Journal of Cancer|February 1, 1994
The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodiesY Olabiran, J A Ledermann, N J Marston, et al.
Pageof 7